eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Pilot study of the efficacy and hepatic safety of raltegravir-based and efavirenz-based regimens when given in combination with tenofovir and emtricitabine in antiretroviral-naïve HIV-infected subjects co-infected with hepatitis C

eagle-i ID


Resource Type

  1. Clinical trial


  1. Intervention
    Raltegravir-based and Efavirenz-based Regimens when Given in Combination with Tenofovir and Emtricitabine
  2. Additional Topic(s)
    HIV therapeutics in HIV and hepatitis C coinfection
  3. Resource Description
    An open-label, randomized clinical trial
  4. Contact
    Shikuma, Cecilia
  5. PI
    Shikuma, Cecilia
  6. Topic
    hepatitis C
  7. Topic
    Human immunodeficiency virus infectious disease
  8. Study Population
    Treatment-naive individuals aged >18 who are coinfected with HIV and hepatitis C and meet Viet Nam Ministry of Health criteria to inititate antiretroviral therapy (CD4 <250 or WHO stage III or IV disease)
  9. Phase
    Phase 4 clinical trial
  10. Performed by
    Shikuma Laboratory
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016